Division of Colorectal & Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, The People's Republic of China.
School of Public Health, Guangxi Medical University, Nanning, The People's Republic of China.
J Transl Med. 2023 Jun 8;21(1):373. doi: 10.1186/s12967-023-04119-1.
The relationship between intestinal microbiome and colorectal cancer (CRC) progression is unclear. This study aims to identify the intestinal microbiome associated with CRC progression and construct predictive labels to support the accurate assessment and treatment of CRC.
The 192 patients included in the study were divided into stage I-II and stage III-IV CRC patients according to the pathological stages, and preoperative stools were collected from both groups for 16S rDNA sequencing of the intestinal microbiota. Pearson correlation and Spearman correlation coefficient analysis were used to analyze the differential intestinal microbiome and the correlation with tumor microenvironment and to predict the functional pathway. XGBoost model (XGB) and Random Forest model (RF) were used to construct the microbiome-based signature. The total RNA extraction from 17 CRC tumor simples was used for transcriptome sequencing.
The Simpson index of intestinal microbiome in stage III-IV CRC were significantly lower than those in stage I-II CRC. Proteus, Parabacteroides, Alistipes and Ruminococcus etc. are significantly enriched genus in feces of CRC patients with stage III-IV. ko00514: Other types of O - glycan biosynthesis pathway is relevant with CRC progression. Alistipes indistinctus was positively correlated with mast cells, immune activators IL-6 and IL6R, and GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM dominantly. The Random Forest (RF) model and eXtreme Gradient Boosting (XGBoost) model constructed with 42 CRC progression-associated differential bacteria were effective in distinguishing CRC patients between stage I-II and stage III-IV.
The abundance and diversity of intestinal microbiome may increase gradually with the occurrence and progression of CRC. Elevated fetal abundance of Proteus, Parabacteroides, Alistipes and Ruminococcus may contribute to CRC progression. Enhanced synthesis of O - glycans may result in CRC progression. Alistipes indistinctus may play a facilitated role in mast cell maturation by boosting IL-6 production. Alistipes indistinctus may work in the correct folding of endoplasmic reticulum proteins in CRC, reducing ER stress and prompting the survival and deterioration of CRC, which may owe to the enhanced PERK expression and activation of downstream UPR by Alistipes indistinctus. The CRC progression-associated differential intestinal microbiome identified in our study can be served as potential microbial markers for CRC staging prediction.
结直肠癌(CRC)进展过程中肠道微生物组的关系尚不清楚。本研究旨在确定与 CRC 进展相关的肠道微生物组,并构建预测标签,以支持对 CRC 的准确评估和治疗。
根据病理分期,将纳入的 192 例患者分为 I-II 期和 III-IV 期 CRC 患者,两组均采集术前粪便进行肠道微生物 16S rDNA 测序。采用 Pearson 相关和 Spearman 相关系数分析,分析差异肠道微生物组与肿瘤微环境的相关性,并预测功能途径。采用 XGBoost 模型(XGB)和随机森林模型(RF)构建基于微生物组的特征。从 17 例 CRC 肿瘤样本中提取总 RNA,进行转录组测序。
III-IV 期 CRC 的肠道微生物 Simpson 指数明显低于 I-II 期 CRC。在 III-IV 期 CRC 患者粪便中丰度明显增加的菌属有变形菌属、拟杆菌属、双歧杆菌属和真杆菌属等。ko00514:其他类型 O-聚糖生物合成途径与 CRC 进展相关。阿利斯特氏菌属与肥大细胞、免疫激活物 IL-6 和 IL6R 呈正相关,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM 占主导地位。采用 42 个与 CRC 进展相关的差异细菌构建的随机森林(RF)模型和极端梯度提升(XGBoost)模型,能有效区分 I-II 期和 III-IV 期 CRC 患者。
随着 CRC 的发生和发展,肠道微生物组的丰度和多样性可能逐渐增加。胎儿丰度升高的变形菌属、拟杆菌属、双歧杆菌属和真杆菌属可能有助于 CRC 的进展。O-聚糖合成增强可能导致 CRC 进展。阿利斯特氏菌属可能通过促进 IL-6 产生来促进肥大细胞成熟,从而在 CRC 中发挥辅助作用。阿利斯特氏菌属可能在 CRC 内质网蛋白的正确折叠中发挥作用,减少内质网应激,促使 CRC 的存活和恶化,这可能归因于阿利斯特氏菌属增强了 PERK 表达并激活了下游 UPR。本研究鉴定的与 CRC 进展相关的差异肠道微生物组可作为 CRC 分期预测的潜在微生物标志物。